1887

Journal of Medical Microbiology logo

Volume 44, Issue 6

Antigenicity of amino-acid sequences from toxin B Free

Abstract

toxins A and B cause antibiotic-associated colitis. Whereas antigenic determinants specifying neutralisation of toxin A have been partially elucidated, those of toxin B remain unknown. To define antigenic determinants of toxin B, synthetic peptides were prepared for five linear sequences selected by computer analysis for putative T and B epitopes. Peptides spanning the carboxy terminal region (aa 2155-2283) were also selected because this region contains repetitive units thought to bind the toxin to cell receptors. Multiple antigenic peptides were synthesised by linking four peptide copies to a core of four lysine residues (tetraMAP). Outbred mice were given four doses of each tetraMAP by intraperitoneal injection and specific immunoglobulins G and A were measured by enzyme-linked immunosorbent assay (ELISA) in serum, ascitic fluid and faeces. All 14 MAPs induced strong IgG responses against the homologous peptide; peptides representing aa 2155-2179 and 2246-2270 induced the strongest responses, of 592 and 493 ELISA units, respectively-although, to a lower extent, all 14 MAPs induced serum and faecal IgA responses against the homologous peptide. All MAPs induced IgG1 and IgG2b subclasses, documenting their capacity to elicit Th2-dependent mucosal immunity. IgG anti-MAPs were assayed for reaction with native toxins A and B; most anti-MAPs recognised the toxins only weakly or did not recognise them. Antibodies against peptide representing aa 2168-2192 recognised both native toxin B (19 ELISA units) and toxin A (2 ELISA units). None of the antibodies neutralised cytotoxicity of either toxin in cell culture. In contrast, four MAPs (aa 2080-2095, 2168-2192, 2220-2244 and 2233-2257) inhibited cytotoxicity when mixed with toxin B before addition to cells; inhibition was mediated by a direct interaction with toxin B.

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
© J. MED. MICROBIOL. 1996
Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-44-6-464
1996-06-01
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jmm/44/6/medmicro-44-6-464.html?itemId=/content/journal/jmm/10.1099/00222615-44-6-464&mimeType=html&fmt=ahah

References

  1. Lyerly D. M., Saum K. E., MacDonald D. K., Wilkins T. D. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun 1985; 47:349–352
     [Google Scholar]
  2. Mitchell T. J., Ketley J. M., Haslam S. C. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 1986; 27:78–85
     [Google Scholar]
  3. Torres J., Jennische E., Lange S., Lӧnnroth I. Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine. Gut 1990; 31:781–785
     [Google Scholar]
  4. Hecht G., Pothoulakis C., LaMont J. T., Madara J. L. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 1988; 82:1516–1524
     [Google Scholar]
  5. Flegel W. A., Muller F., Daubener W., Fischer H.-G., Hadding U., Northof F. H. Cytokines response by human monocytes to Clostridium difficile toxin A and toxin B. Infect Immun 1991; 59:3659–3666
     [Google Scholar]
  6. Miller P. D., Pothoulakis C., Baeker T. R., LaMont J. T., Rothstein T. L. Macrophage-dependent stimulation of T cell-depleted spleen cells by Clostridium difficile toxin A and calcium ionophore. Cell Immunol 1990; 126:155–163
     [Google Scholar]
  7. Malomi W., Paradisi S., Dupuis M. L., Fiorentini C., Ramoni C. Enhancement of cell-mediated cytotoxicity by Clostridium difficile toxin A: an in vitro study. Toxicon 1991; 29:417–428
     [Google Scholar]
  8. Pothoulakis C., Sullivan R., Melnick D. A. Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest 1988; 81:1741–1745
     [Google Scholar]
  9. Pothoulakis C., Karmeli F., Kelly C. P. Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum. Gastroenterology 1993; 105:701–707
     [Google Scholar]
  10. Hecht G., Koutsouris A., Pothoulakis C., LaMont J. T., Madara J. L. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 1992; 102:416–423
     [Google Scholar]
  11. Siffert J. C., Baldacini O., Kuhry J. G. EfFects of Clostridium difficile toxin B on human monocytes and macrophages: possible relationship with cytoskeletal rearrangement. Infect Immun 1993; 61:1082–1090
     [Google Scholar]
  12. Kelly C. P., Pothoulakis C., LaMont J. T. Clostridium difficile colitis. N Engl J Med 1994; 330:257–262
     [Google Scholar]
  13. Viscidi R., Laughon B. E., Yolken R. Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 1983; 148:93–100
     [Google Scholar]
  14. Leung D. Y. M., Kelly C. P., Boguniewicz M., Pothoulakis C., LaMont J. T., Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991; 118:633–637
     [Google Scholar]
  15. Wamy M., Vaerman, J-P., Avesani V., Delmee M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994; 62:384–389
     [Google Scholar]
  16. Johnson S., Gerding D. N., Janoff E. N. Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile. J Infect Dis 1992; 166:1287–1294
     [Google Scholar]
  17. Femie D. S., Thomson R. O., Batty I., Walker P. D. Active and passive immunization to protect against antibiotic associated caecitis in hamsters. Dev Biol Stand 1983; 53:325–332
     [Google Scholar]
  18. Kim P.-H., Iaconis J. P., Rolfe R. D. Immunization of adult hamsters against Clostridium rfα?ce-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun 1987; 55:2984–2992
     [Google Scholar]
  19. Libby J. M., Jortner B. S., Wilkins T. D. EfFects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun 1982; 36:822–829
     [Google Scholar]
  20. Ketley J. M., Mitchell T. J., Candy D. C. A., Burdon D. W., Stephen J. The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits. J Med Microbiol 1987; 24:41–52
     [Google Scholar]
  21. Barroso L. A., Wang, S-Z., Phelps C. J., Johnson J. L., Wilkins T. D. Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res 1990; 18:4004
     [Google Scholar]
  22. Dove C. H., Wang, S-Z., Price S. B. Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 1990; 58:480–488
     [Google Scholar]
  23. Barroso L. A., Moncrief J. S., Lyerly D. M., Wilkins T. D. Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity. Microb Pathog 1994; 16:297–303
     [Google Scholar]
  24. von Eichel-Streiber C., Laufenberg-Feldmann R., Sartingen S., Schulze J., Sauerbom M. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet 1992; 233:260–268
     [Google Scholar]
  25. Frey S. M., Wilkins T. D. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun 1992; 60:2488–2492
     [Google Scholar]
  26. Lyerly D. M., Phelps C. J., Toth J., Wilkins T. D. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun 1986; 54:70–76
     [Google Scholar]
  27. Tam J. P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigen peptide system. Proc Natl Acad Sci USA 1988; 85:5409–5413
     [Google Scholar]
  28. Reynolds S. R., Dahl C. E., Ham D. A. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol 1994; 152:193–200
     [Google Scholar]
  29. Torres J. F., Lonnroth I. Production, purification and characterisation of Clostridium difficile toxic proteins different from toxin A and from toxin B. Biochim Biophys Acta 1989; 998:151–157
     [Google Scholar]
  30. Tam J. P., Clavijo P., Lu, Y-A., Nussenzweig V., Nussenzweig R., Zavala F. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J Exp Med 1990; 171:299–306
     [Google Scholar]
  31. Coffman R. L., Seymour B. W. P., Lehman D. A. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988; 102:5–28
     [Google Scholar]
  32. Mosmann T. R., Coffman R. L. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145–173
     [Google Scholar]
  33. Daubener W., Leiser E., von Eichel-Streiber C., Hadding U. Clostridium difficile toxins A and B inhibit human immune response in vitro. Infect Immun 1988; 56:1107–1112
     [Google Scholar]
  34. Emini E. A., Jameson B. A., Wimmer E. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature 1983; 304:699–703
     [Google Scholar]
  35. Lyerly D. M., Carrig P. E., Wilkins T. D. Nonspecific binding of mouse monoclonal antibodies to Clostridium difficile toxins A and B. Curr Microbiol 1989; 19:303–306
     [Google Scholar]
  36. von Eichel-Streiber C., Sauerbom M. Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glyco-syltransferases. Gene 1990; 96:107–113
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-44-6-464
Loading
Antigenicity of amino-acid sequences from Clostridium difficile toxin B
J. Med. Microbiol. 44, 464 (1996); https://doi.org/10.1099/00222615-44-6-464
/content/journal/jmm/10.1099/00222615-44-6-464
/content/journal/jmm/10.1099/00222615-44-6-464
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error